641 results on '"Choo, Myung‐Soo"'
Search Results
2. Summary of the 2023 report of the international consultation on incontinence interstitial cystitis/bladder pain syndrome (IC/BPS) committee
3. Intravital imaging and single cell transcriptomic analysis for engraftment of mesenchymal stem cells in an animal model of interstitial cystitis/bladder pain syndrome
4. A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
5. Mesenchymal stem cells with an enhanced antioxidant capacity integrate as smooth muscle cells in a model of diabetic detrusor underactivity.
6. Current and Future Directions of Stem Cell Therapy for Bladder Dysfunction
7. Stem cell therapy for interstitial cystitis/bladder pain syndrome.
8. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study
9. A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder
10. Drug persistence and compliance affect patient-reported outcomes in overactive bladder syndrome
11. Urodynamic study for distinguishing multiple system atrophy from Parkinson disease
12. Induction of detrusor underactivity by extensive vascular endothelial damages of iliac arteries in a rat model and its pathophysiology in the genetic levels
13. N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model
14. The Therapeutic Effect of Solifenacin Succinate on the Recovery From Voiding Dysfunction After Radical Prostatectomy in Men With Clinically Localized Prostate Cancer: A Prospective, Randomized, Controlled Study
15. Expressions of vaginal endothelial nitric oxide synthase and phosphodiesterase 5 in female sexual dysfunction: a pilot study
16. A Multicenter, Open-Label, Observational Study Evaluating the Quality of Life After Using a Hydrophilic-Coated Catheter (SpeediCath) With Self-Intermittent Catheterization
17. Safety and Efficacy of 8-mg Once-daily vs 4-mg Twice-daily Silodosin in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (SILVER Study): A 12-Week, Double-blind, Randomized, Parallel, Multicenter Study
18. Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion
19. Ileal Augmentation Cystoplasty Combined with Ileal Ureter Replacement After Radical Treatment for Cervical Cancer
20. Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I Study
21. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion
22. Health Related Quality of Life in Patients with Side‐Effects after Antimuscarinic Treatment for Overactive Bladder
23. Effect of preoperative urodynamic detrusor overactivity on post-prostatectomy incontinence: a systematic review and meta-analysis
24. Hand-assisted laparoscopic bladder cuff excision via the same hand port as that used for nephroureterectomy
25. A prospective, observational study to assess the association between dry mouth and solifenacin treatment in patients with overactive bladder syndrome
26. Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
27. The Long-term Effect of Alfuzosin in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: Evaluation of Voiding and Storage Function With Respect to Bladder Outlet Obstruction Grade and Contractility
28. Most Bothersome Symptom and Symptom Specific Goal Achievement in Patients With Benign Prostatic Obstruction: A Prospective Open Label Study
29. Bladder capacity in kidney transplant patients with end-stage renal disease
30. Long-term durability, functional outcomes, and factors associated with surgical failure of tension-free vaginal tape procedure
31. Safety and efficacy of desmopressin for the treatment of nocturia in elderly patients: a cohort study
32. MESENCHYMAL STEM CELLS ATTENUATES KETAMINE-INDUCED INTERSTITIAL CYSTITIS: MP68-19
33. A Prospective Multicenter Randomized Comparative Study Between the U- and H-type Methods of the TVT SECUR Procedure for the Treatment of Female Stress Urinary Incontinence: 1-Year Follow-Up
34. Effects of different types of hysterectomies on postoperative urodynamics and lower urinary tract symptoms
35. Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder?*
36. MP52-14 EXPRESSIONS OF VAGINAL PHOSPHODIESTERASE 5 AND NITRIC OXIDE SYNTHASE IN FEMALE SEXUAL DYSFUNCTION
37. PD20-10 PROSPECTIVE, MULTICENTER, RANDOMIZED CLINICAL TRIAL COMPARING THE EFFECT OF HYDRODISTENTION AND TRANSURTHRAL FULGURATION OF BLADDER IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS
38. PD16-10 THE EFFECT OF COMBINED SYSTEMATIZED BEHAVIORAL MODIFICATION EDUCATION PROGRAM (SBMP) WITH DDAVP IN PATIENTS WITH NOCTURIA: A PROSPECTIVE, MULTICENTER, RANDOMIZED, AND PARALLEL STUDY
39. MP19-06 MESENCHYMAL STEM-CELL THERAPY ALLEVIATES INTERSTITIAL CYSTITIS BY ACTIVATING WNT SIGNALING PATHWAY
40. MP3-14 CHANGES OF THE URINARY NERVE GROWTH FACTOR (NGF) LEVELS AFTER RELIEF OF OBSTRUCTION IN THE PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC OBSTRUCTION (BPO) USING HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)
41. Analysis of female voiding dysfunction: a prospective, multi-center study
42. Pelvic floor muscle training using an extracorporeal biofeedback device for female stress urinary incontinence
43. MP02-18 EFFICACY AND SAFETY OF DA8010, A NOVEL M3 ANTAGONIST, IN PATIENTS WITH OVERACTIVE BLADDER: RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY
44. Reply by Authors
45. Features of Various Bladder Lesions and Their Impact on Clinical Symptoms and Recurrence in Interstitial Cystitis
46. Efficacy of TVT-SECUR and factors affecting cure of female stress urinary incontinence: 3-year follow-up
47. Management of recurrent stress urinary incontinence after failed midurethral sling: tape tightening or repeat sling?
48. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study
49. Transobturator adjustable tape for severe stress urinary incontinence and stress urinary incontinence with voiding dysfunction
50. The Long Term (5-Years) Objective TVT Success Rate Does Not Depend on Predictive Factors at Multivariate Analysis: A Multicentre Retrospective Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.